Ramipril in High-Risk Patients With COVID-19 https://t.co/xOJvh9j7aH https://t.co/zoD70h9sMq
Ramipril in High-Risk Patients With COVID-19 https://t.co/dCJsjpR6PG #PublicaSergas #CHUS #CHUVI
RT @JACCJournals: New #JACC research examines ACE-I effect in older patients: There was no major impact for incidence or severity with #COV…
RT @JACCJournals: New #JACC research examines ACE-I effect in older patients: There was no major impact for incidence or severity with #COV…
RT @JACCJournals: New #JACC research examines ACE-I effect in older patients: There was no major impact for incidence or severity with #COV…
RT @JACCJournals: New #JACC research examines ACE-I effect in older patients: There was no major impact for incidence or severity with #COV…
RT @JACCJournals: New #JACC research examines ACE-I effect in older patients: There was no major impact for incidence or severity with #COV…
RT @JACCJournals: New #JACC research examines ACE-I effect in older patients: There was no major impact for incidence or severity with #COV…
RT @JACCJournals: New #JACC research examines ACE-I effect in older patients: There was no major impact for incidence or severity with #COV…
RT @JACCJournals: New #JACC research examines ACE-I effect in older patients: There was no major impact for incidence or severity with #COV…
RT @JACCJournals: New #JACC research examines ACE-I effect in older patients: There was no major impact for incidence or severity with #COV…
RT @JACCJournals: New #JACC research examines ACE-I effect in older patients: There was no major impact for incidence or severity with #COV…
RT @JACCJournals: New #JACC research examines ACE-I effect in older patients: There was no major impact for incidence or severity with #COV…
New #JACC research examines ACE-I effect in older patients: There was no major impact for incidence or severity with #COVID19. Learn more: https://t.co/vN5Wff1guQ @ignamatsant https://t.co/63hTAvQ2SU
Ramipril in High-Risk Patients With COVID-19. https://t.co/4WsA2oIxdu
Ramipril in High-Risk Patients With COVID-19 Ramipril had no impact on the incidence or severity of COVID-19. This analysis supports the maintenance of RAAS inhibitor. https://t.co/BpdpAh7KMf
RT @cladelucia: New research in @JACCJournals suggests keeping renin-angiotensin-aldosterone system treatment in #older patients has no maj…
RT @cladelucia: New research in @JACCJournals suggests keeping renin-angiotensin-aldosterone system treatment in #older patients has no maj…
RT @cladelucia: New research in @JACCJournals suggests keeping renin-angiotensin-aldosterone system treatment in #older patients has no maj…
New research in @JACCJournals suggests keeping renin-angiotensin-aldosterone system treatment in #older patients has no major impact on incidence or severity with #COVID19. #PrecisionMedicine #aging #geriatrics #medicine #research #Medical Learn more: ht
RT @ArashArya_EP: Ramipril in High-Risk Patients With COVID-19 In a high-risk population of older patients with cardiovascular disease, ra…
Ramipril in High-Risk Patients With COVID-19 In a high-risk population of older patients with cardiovascular disease, randomization to ramipril had no impact on the incidence or severity of COVID-19. https://t.co/ELZDsy11bS
RT @WorldMedicineN1: Más evidencia, para no modificar el tratamiento antihipertensivo en pacientes con COVID 19…
Más evidencia, para no modificar el tratamiento antihipertensivo en pacientes con COVID 19 Ramipril in High-Risk Patients With COVID-19 https://t.co/GrNCk4CoxQ
In a small RCT of ramipril vs placebo s/p TAVR in Spain, an interim nonprespecified analysis (of N=102) did not show a difference in #COVID19 diagnosis rate https://t.co/Rz8TWhyXsL @JACCJournals https://t.co/RRNJS2ip1L
RT @AnastasiaSMihai: Ramipril in High-Risk #Covid_19 Pts @JACCJournals https://t.co/F7q2mRORym 📌retrosp analysis of RASTAVI #RCT 📌Mean ag…
RT @AnastasiaSMihai: Ramipril in High-Risk #Covid_19 Pts @JACCJournals https://t.co/F7q2mRORym 📌retrosp analysis of RASTAVI #RCT 📌Mean ag…
RT @AnastasiaSMihai: Ramipril in High-Risk #Covid_19 Pts @JACCJournals https://t.co/F7q2mRORym 📌retrosp analysis of RASTAVI #RCT 📌Mean ag…
Ramipril in High-Risk Patients With COVID-19 | JACC: Journal of the American College of Cardiology https://t.co/oFV1zKmPrf
Ramipril in High-Risk #Covid_19 Pts @JACCJournals https://t.co/F7q2mRORym 📌retrosp analysis of RASTAVI #RCT 📌Mean age 82± 6 yrs, 56.9%🕺 📌Risk of #COVID19 was⬆️in older pts, those with #AFib & lower hematocrit 📌Higher #BMI only factor⬆️mortality rate
【RAS-i有用性検討RCT中にCOVID-19となった例を比較すると?/ JACC】 TAVI成功102例ランダム化、予定外中途解析:ACE阻害薬群の5例、対照群6例がCOVID-19と診断。入院酸素療法を要したのは順に2例と3例、死亡は2例ずつ。 https://t.co/uH7dTWAkSR https://t.co/E6qAg1u12C
I probably missed this if it was a preprint in #covidmania but small RCT of ramipril in #COVID19 patients doesn't make a difference either way. https://t.co/3jwI3vRU8T
RT @ManlioMarquez: @ElectroSiac recomienda!
Ramipril in High #Risk Patients With #Covid19 | Social Reach: Low https://t.co/ytqVmn267w
RT @vic_pallares: Ramipril in High Risk Patients with COVID-19 https://t.co/z6ZVudn1i1
n a high risk population of old patients with cardiovascular disease, randomization to Ramipril had no impact in the incidence or severity of COVID-19.
RT @vic_pallares: Ramipril in High Risk Patients with COVID-19 https://t.co/z6ZVudn1i1
RT @vic_pallares: Ramipril in High Risk Patients with COVID-19 https://t.co/z6ZVudn1i1
RT @vic_pallares: Ramipril in High Risk Patients with COVID-19 https://t.co/z6ZVudn1i1
RT @ana_apiecar: In a #high risk population of #old patients with #cardiovascular disease, randomization to #Ramipril had #no impact in the…
In a #high risk population of #old patients with #cardiovascular disease, randomization to #Ramipril had #no impact in the #incidence or #severity of #COVID-19. This analysis supports the #maintenance of RAAS-inhibitor treatment during COVID-19 crisis. htt
Ramipril in High Risk Patients with COVID-19 https://t.co/z6ZVudn1i1
Thanks @NROK1227 @JACCJournals
RT @NROK1227: @hswapnil @adambress @asouth_neph @jordy_bc @thebyrdlab @TomHanffMD @Nephro_Sparks @JulioChirinosMd @CircRes Small RCT for a…
@hswapnil @adambress @asouth_neph @jordy_bc @thebyrdlab @TomHanffMD @Nephro_Sparks @JulioChirinosMd @CircRes Small RCT for a different reason but it's a start! https://t.co/meAJZqArSg
https://t.co/meAJZqArSg unfortunately small numbers but an RCT in regard to ace I hibators and covid-19
RT @ignamatsant: Available online in @JACCJournals the results of our randomized trial “Ramipril in high risk patients with #COVIDー19 “ htt…
RT @ignamatsant: Best evidence regarding treatment in #COVIDー19 patients is that from RCT. See the effect of Ramipril in RASTAVI Trial pub…
RT @ignamatsant: Best evidence regarding treatment in #COVIDー19 patients is that from RCT. See the effect of Ramipril in RASTAVI Trial pub…
Best evidence regarding treatment in #COVIDー19 patients is that from RCT. See the effect of Ramipril in RASTAVI Trial published in @JACCJournals https://t.co/aRIJvMGKTE
RT @Jp_vilchez: Ramipril aleatorizado en pacientes de alto riesgo (TAVI) e infección por COVID-19, excelente análisis no pre-especificado q…
Ramipril in High Risk Patients with COVID-19 article. Analysis supports the maintenance of RAAS-inhibitor treatment during COVID-19 crisis. https://t.co/2LsfiSVMJq
RT @ManlioMarquez: @ElectroSiac recomienda!
@ElectroSiac recomienda!
RT @Borjaibanez1: No matter how large or good is the observational study... a RCT is always better evidence. To my knowledge this is the fi…
RT @Borjaibanez1: No matter how large or good is the observational study... a RCT is always better evidence. To my knowledge this is the fi…
RT @ignamatsant: Available online in @JACCJournals the results of our randomized trial “Ramipril in high risk patients with #COVIDー19 “ htt…
Ramipril in High Risk Patients with COVID-19 | JACC: Journal of the American College of Cardiology https://t.co/Lfin9bxl4B
Study: Ramipril in High Risk Patients with COVID-19 – via @JACCJournals https://t.co/0MZhEfxGOI
RT @ignamatsant: Available online in @JACCJournals the results of our randomized trial “Ramipril in high risk patients with #COVIDー19 “ htt…
Ramipril aleatorizado en pacientes de alto riesgo (TAVI) e infección por COVID-19, excelente análisis no pre-especificado que muestra seguridad de los IECAs https://t.co/wSSpcTbVh3
RT @ignamatsant: Available online in @JACCJournals the results of our randomized trial “Ramipril in high risk patients with #COVIDー19 “ htt…
Very interesting article on “Ramipril in high risk patients with #COVIDー19 “ supports the maintenance of RAAS-inhibitor treatment during COVID-19 crisis. #Cardiology #cardiovascular #cardiovasculardisease #Doctors #physician #NHS #RCGP
RT @ignamatsant: Available online in @JACCJournals the results of our randomized trial “Ramipril in high risk patients with #COVIDー19 “ htt…
RT @Borjaibanez1: No matter how large or good is the observational study... a RCT is always better evidence. To my knowledge this is the fi…
RT @Borjaibanez1: No matter how large or good is the observational study... a RCT is always better evidence. To my knowledge this is the fi…
RT @Borjaibanez1: No matter how large or good is the observational study... a RCT is always better evidence. To my knowledge this is the fi…
RT @ignamatsant: Available online in @JACCJournals the results of our randomized trial “Ramipril in high risk patients with #COVIDー19 “ htt…
No matter how large or good is the observational study... a RCT is always better evidence. To my knowledge this is the first RCT in high risk for COVID19 patients randomly allocated toACEi or not.
RT @ignamatsant: Available online in @JACCJournals the results of our randomized trial “Ramipril in high risk patients with #COVIDー19 “ htt…
PubMed- https://t.co/B7QkkLlEXE Ramipril in High Risk Patients With COVID-19 @HUCA_Asturias #publiHUCA #COVIDー19 #COVID19
RT @ignamatsant: Available online in @JACCJournals the results of our randomized trial “Ramipril in high risk patients with #COVIDー19 “ htt…
RT @ignamatsant: Available online in @JACCJournals the results of our randomized trial “Ramipril in high risk patients with #COVIDー19 “ htt…
RT @ignamatsant: Available online in @JACCJournals the results of our randomized trial “Ramipril in high risk patients with #COVIDー19 “ htt…
Ramipril in High Risk Patients with COVID-19 https://t.co/kfUUTrXfON
RT @ignamatsant: Available online in @JACCJournals the results of our randomized trial “Ramipril in high risk patients with #COVIDー19 “ htt…
RT @ignamatsant: Available online in @JACCJournals the results of our randomized trial “Ramipril in high risk patients with #COVIDー19 “ htt…
RT @ignamatsant: Available online in @JACCJournals the results of our randomized trial “Ramipril in high risk patients with #COVIDー19 “ htt…
RT @ignamatsant: Available online in @JACCJournals the results of our randomized trial “Ramipril in high risk patients with #COVIDー19 “ htt…
RT @ignamatsant: Available online in @JACCJournals the results of our randomized trial “Ramipril in high risk patients with #COVIDー19 “ htt…
RT @ignamatsant: Available online in @JACCJournals the results of our randomized trial “Ramipril in high risk patients with #COVIDー19 “ htt…
RT @ignamatsant: Available online in @JACCJournals the results of our randomized trial “Ramipril in high risk patients with #COVIDー19 “ htt…
RT @ignamatsant: Available online in @JACCJournals the results of our randomized trial “Ramipril in high risk patients with #COVIDー19 “ htt…
RT @ignamatsant: Available online in @JACCJournals the results of our randomized trial “Ramipril in high risk patients with #COVIDー19 “ htt…
RT @ignamatsant: Available online in @JACCJournals the results of our randomized trial “Ramipril in high risk patients with #COVIDー19 “ htt…
RT @FormigaFrancesc: Ramipril in High Risk Patients with COVID-19 https://t.co/G3RDFV5xXY
RT @ignamatsant: Available online in @JACCJournals the results of our randomized trial “Ramipril in high risk patients with #COVIDー19 “ htt…
RT @FormigaFrancesc: Ramipril in High Risk Patients with COVID-19 https://t.co/G3RDFV5xXY
RT @ignamatsant: Available online in @JACCJournals the results of our randomized trial “Ramipril in high risk patients with #COVIDー19 “ htt…
RT @ignamatsant: Available online in @JACCJournals the results of our randomized trial “Ramipril in high risk patients with #COVIDー19 “ htt…
RT @ignamatsant: Available online in @JACCJournals the results of our randomized trial “Ramipril in high risk patients with #COVIDー19 “ htt…
RT @FormigaFrancesc: Ramipril in High Risk Patients with COVID-19 https://t.co/G3RDFV5xXY
RT @luisrpadial: Ramipril in High Risk Patients with COVID-19 https://t.co/wEpgChSd1O
RT @FormigaFrancesc: Ramipril in High Risk Patients with COVID-19 https://t.co/G3RDFV5xXY
RT @ignamatsant: Available online in @JACCJournals the results of our randomized trial “Ramipril in high risk patients with #COVIDー19 “ htt…